Literature DB >> 9558084

Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.

H Fukuyama1, M Adachi, S Suematsu, K Miwa, T Suda, N Yoshida, S Nagata.   

Abstract

Fas is a member of the TNF receptor family. Binding of Fas ligand to Fas induces apoptosis in Fas-bearing cells. Fas is expressed in various cells, including thymocytes, peripheral T cells, and activated B cells. The mouse lpr mutation is a loss of function mutation of Fas. MRL-lpr/lpr mice develop lymphadenopathy and splenomegaly, and produce multiple autoantibodies, which results in autoimmune disease. In this report, we describe the establishment of a line of Fas transgenic MRL-lpr mice in which mouse Fas cDNA was expressed using the T cell-specific murine lck promoter. The transgenic mice expressed functional Fas in thymocytes and peripheral T cells, but not in B cells. The transgenic mice did not accumulate abnormal T cells (Thy-1+ B220+), but still accumulated B cells (Thy-1- B220+); they produced a large quantity of Igs (IgG1 and IgG2a), including anti-DNA Abs, and developed glomerulonephritis. These results suggest that autoreactive or activated B cells must be killed through Fas expressed in the B cells by the Fas ligand expressed in activated T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558084

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Death receptor signaling and autoimmunity.

Authors:  Richard M Siegel; Jagan Muppidi; Margaret Roberts; Melissa Porter; Zhengqi Wu
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Both perforin and FasL are required for optimal CD8 T cell control of autoreactive B cells and autoantibody production in parent-into-F1 lupus mice.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Roman Puliaev; Irina Puliaeva; Charles S Via
Journal:  Clin Immunol       Date:  2018-06-22       Impact factor: 3.969

3.  Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.

Authors:  M Hishii; J T Kurnick; T Ramirez-Montagut; F Pandolfi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

4.  Differential role of SLP-76 domains in T cell development and function.

Authors:  Lalit Kumar; Vadim Pivniouk; Miguel A de la Fuente; Dhafer Laouini; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  FAS mRNA editing in Human Systemic Lupus Erythematosus.

Authors:  Jianming Wu; Fenglong Xie; Kun Qian; Andrew W Gibson; Jeffrey C Edberg; Robert P Kimberly
Journal:  Hum Mutat       Date:  2011-08-11       Impact factor: 4.878

6.  Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice.

Authors:  Djemel Aït-Azzouzene; Dwight H Kono; Rosana Gonzalez-Quintial; Louise J McHeyzer-Williams; Min Lim; Dilki Wickramarachchi; Tobias Gerdes; Amanda L Gavin; Patrick Skog; Michael G McHeyzer-Williams; David Nemazee; Argyrios N Theofilopoulos
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

Review 7.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

Review 8.  Somatic mutagenesis in autoimmunity.

Authors:  Thiago Detanico; James B St Clair; Katja Aviszus; Greg Kirchenbaum; Wenzhong Guo; Lawrence J Wysocki
Journal:  Autoimmunity       Date:  2013-01-18       Impact factor: 2.815

9.  Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.

Authors:  Peter B Stranges; Jessica Watson; Cristie J Cooper; Caroline-Morgane Choisy-Rossi; Austin C Stonebraker; Ryan A Beighton; Heather Hartig; John P Sundberg; Stein Servick; Gunnar Kaufmann; Pamela J Fink; Alexander V Chervonsky
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

10.  Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice.

Authors:  Norihiko Watanabe; Koichi Ikuta; Sazuku Nisitani; Tsutomu Chiba; Tasuku Honjo
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.